Webinar Series DHS SBIR Phase 0 Webinar Series Explore past webinars featuring experts from DHS SBIR and program partner, Dawnbreaker, as they guide small businesses through the proposal process
These enzymes evolved to break down dietary protein, and they treat therapeutic peptides the same way First-pass metabolism: Any peptide that survives digestion and crosses the intestinal wall faces further breakdown in the liver before reaching systemic circulation Size and charge: CJC-1295 (30 amino acids) and Ipamorelin (5 amino acids) are both too large and too hydrophilic to passively cross the intestinal epithelium in meaningful amounts Subcutaneous injection bypasses all of these barriers, delivering the intact peptide directly into the bloodstream with near-100% bioavailability
Beyond technique, knowing your baseline B12 status through biomarker testing can help your provider determine whether MIC B12 aligns with your metabolic profile
Cell Cycle 15 (4), 559572
and critically human PK data (unavailable because no completed clinical trials have been published)
Improvements may include reduced bloating, less abdominal discomfort, better digestion, and increased energy
